Art. 2 Regulation (EU) 2016/128

Compositional requirements

In forcesince 25 Sep 2015cited 6×
1.

Food for special medical purposes is classified in the following three categories:

(a)

nutritionally complete food with a standard nutrient formulation which, used in accordance with the manufacturer's instructions, may constitute the sole source of nourishment for the persons for whom it is intended;

(b)

nutritionally complete food with a nutrient-adapted formulation specific for a disease, disorder or medical condition which, used in accordance with the manufacturer's instructions, may constitute the sole source of nourishment for the persons for whom it is intended;

(c)

nutritionally incomplete food with a standard formulation or a nutrient-adapted formulation specific for a disease, disorder or medical condition which is not suitable to be used as the sole source of nourishment.

The food referred to in points (a) and (b) of the first subparagraph may also be used as a partial replacement or as a supplement to the patient's diet.

2.

The formulation of food for special medical purposes shall be based on sound medical and nutritional principles. Its use, in accordance with the manufacturer's instructions, shall be safe, beneficial and effective in meeting the specific nutritional requirements of the persons for whom it is intended, as demonstrated by generally accepted scientific data.

3.

Food for special medical purposes developed to satisfy the nutritional requirements of infants shall comply with the compositional requirements set out in Part A of Annex I.

Food for special medical purposes other than that developed to satisfy the nutritional requirements of infants shall comply with the compositional requirements set out in Part B of Annex I.

4.

The compositional requirements set out in Annex I shall apply to the food for special medical purposes ready for use, marketed as such or after preparation in accordance with the manufacturer's instructions.

  • Judgment of the Court (Second Chamber) of 27 October 2022. Orthomol pharmazeutische Vertriebs GmbH v Verband Sozialer Wettbewerb eV.Decision

    In those circumstances, the Oberlandesgericht Düsseldorf (Higher Regional Court, Düsseldorf) decided to stay the proceedings and to refer the following questions to the Court of Justice for a preliminary ruling: Under what circumstances …

    27 Oct 2022 · 62021CJ0418

  • Judgment of the Court (Second Chamber) of 2 March 2023. Kwizda Pharma GmbH v Landeshauptmann von Wien.Decision

    Article 2 of that delegated regulation states: ‘(1) Food for special medical purposes is classified in the following three categories: nutritionally complete food with a standard nutrient formulation which, used in accordance with the …

    2 Mar 2023 · 62021CJ0760

  • BVerwG, Urteil vom 17. September 2021 - 3 C 20/20Decision

    … 9 Abs. 1 sowie Art. 11 Abs. 1 Buchst. a der Verordnung <EU> Nr. 609/2013 i.V.m. Art. 2 Abs. 2 Satz 2 der Delegierten Verordnung <EU> 2016/128; vgl. zur entsprechenden Rechtslage unter Geltung der Diätverordnung BGH, Urteile vom 2. Oktober …

    17 Sep 2021 · WBRE202100946

  • Verordnung über Lebensmittel für bestimmte Verbrauchergruppen9Law

    … und Futtermittelgesetzbuches wird bestraft, wer vorsätzlich oder fahrlässig entgegen Artikel 1 in Verbindung mit Artikel 2 Absatz 3 der Delegierten Verordnung (EU) 2016/128 der Kommission vom 25. September 2015 zur Ergänzung der …

  • Verordnung über Lebensmittel für bestimmte Verbrauchergruppen9Law

  • BVerwG, Urteil vom 17. September 2021 - 3 C 21/20Decision

    … 9 Abs. 1 sowie Art. 11 Abs. 1 Buchst. a der Verordnung <EU> Nr. 609/2013 i.V.m. Art. 2 Abs. 2 Satz 2 der Delegierten Verordnung <EU> 2016/128; vgl. zur entsprechenden Rechtslage unter Geltung der Diätverordnung BGH, Urteile vom 2. Oktober …

    17 Sep 2021 · WBRE202100945